Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

NCT00098670

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

NCT01358253

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00398112

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +16 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

NCT00802737

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: GSK Investigational Site Örebro, Sweden

GSK Investigational Site Stockholm, Sweden

View Trial Details

Completed

A Phase I/II Study of GX15-070MS in Untreated CLL

NCT00600964

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: University of CA- San Diego La Jolla, California, United States

Lombardi Cancer Center Washington D.C., District of Columbia, United States

Milton S Hershey Medical Center Penn State Cancer Institute Hershey, Pennsylvania, United States

UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00290810

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +15 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

NCT00003538

Conditions: Adnexal Diseases, Anemia, Blast Crisis, +110 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

NCT00003572

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003960

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

Center for Cancer Treatment and Research Columbia, South Carolina, United States

View Trial Details

Completed

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003962

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions